In connection with a study to determine whether man could be successfully immunized against bacillary dysentery it was necessary to determine the infective dose of dysentery bacilli by feeding living Shigella to human volunteers. The only previous information concerning the susceptibility of man to experimental infection is contained in a few published observations' 3 of accidental laboratory-infections.
These indicated that man was susceptible to rather large doses of dysentery bacilli, but they gave no other information. In the study mentioned above human volunteers were fed graded doses of recently isolated strains of Flexner W organisms which had been shown to be sensitive to sulfadiazine. For details of the source, mouse virulence, and sulfadiazine susceptibility, see table 1 . The technique by which susceptibility to sulfadiazine was determined is described in a previous paper. 2 Before a volunteer was accepted for participation in the study he was required to pass a physical examination. Two rectal swabs, collected on different days, from each volunteer were cultured for Shigella on S. S. agar and only those individuals with negative cultures and a negative history of a recent diarrheal illness were accepted.
Oral temperatures were taken once daily on each volunteer for one week prior to administration of the challenge dose. During the day of the challenge, for at least 48 hours thereafter, and during clinical illness temperatures were taken four times daily. Temperature readings were then made twice a day until two weeks after the challenge.
Rectal swabs from each volunteer were cultured at daily intervals for three days just prior to exposure to the challenge infection. Rectal swab cultures were also made daily while the patients were under observation following their exposure to challenge infection.
The organisms used for challenge were grown on veal infusion agar slants, the growth washed off with distilled water just prior to challenge, and the number of organisms per cubic centimeter was adjusted by comparison with nephelometer standards. The results of nephelometric standardization were checked by plate counts until it was decided that nephelometer measurements were accurate enough for the purpose. The subjects were first prepared for the challenge by giving each one dram of paregoric 3½V2 hours after a meal, followed 30 minutes later by two gm. of powdered sodium bicarbonate in one ounce of water. Five minutes later, the dysentery bacilli were given, suspended in one-half pint of milk. The administration of paregoric was repeated at the end of 3 and 6 hours.
It was later thought that the use of milk might be interfering with the effects of the challenge material. It was, therefore, discontinued and the later challenge doses were administered in a glass of water, followed immediately by another glass of water, in order to dilute the gastric secretions and to wash the material through the stomach quickly.
The subjects used in determining the infective dose were challenged in groups of four. It was planned that each of those of the first group be fed 100 million living Shigella organisms. Failing to infect two of the four, the next group were to receive one billion living organisms, and subsequent groups larger numbers in an attempt to find the dosage that produced a fifty per cent, or more, attack rate in unvaccinated controls.
Since we were interested only in whether or not dysentery could be produced in a given individual, sulfadiazine was administered as soon as a definite diagnosis of dysentery could be made. In later experiments, after the infective dose had been established, those who did not show signs or symptoms of dysentery within four days after challenge were given a course of sulfadiazine therapy in order to prevent them from becoming dysentery carriers. The dosage of sulfadiazine was approximately one grain per pound of body weight per day in four divided doses for five to seven days.
All organisms isolated from any of the daily rectal swabs were identified by cultural, biochemical, tinctorial, and immunologic tests. Daily swabs for culture were taken until at least five consecutive negative cultures were obtained. After cessation of sulfadiazine therapy usually at least two negatives were obtained and in no case was any subject released from isolation until at least three successive negative cultures were obtained on specimens taken 24 hours apart.
In the first groups of experiments strain FW I was used and, as shown in table 2, the volunteers given 100 million, 1 billion, and 10 billion organisms, respectively, in milk failed to develop definite clinical dysentery. Two men given 10 billion organisms in water developed mild dysentery. There was no temperature elevation, but these two patients had cramps, headache, chills, and passed frequent, watery stools, one having six bowel movements and the other nine in one day.
On the basis of these findings it was believed the end-point was being reached and accordingly the four volunteers in the next group were fed only 15 billion organisms, strain FW I, in water. Since none of these showed any signs or symptoms during the subsequent 48 hours, they were given 15 billion more organisms on each of the next two days. Since there was virtually no result from this, 50 billion dysentery bacilli were administered on the fourth day. The only reactions to these massive doses of organisms were mild headache, anorexia, slight abdominal cramps, and an occasional soft stool.
It was obvious that strain FW I, although the most virulent for mice, was not virulent enough to produce clean-cut clinical infection in In contrast to the essentially negative findings with the infected feces alone, three of the four subjects fed feces plus the mixture of four strains of dysentery bacilli developed definite signs and symptoms of clinical dysentery. Moderately severe cramps, headache, and vomiting appeared about 12 hours after the test dose was given. On the following day the temperature rose to 103.4, 104.4, and 1050, respectively, and the patients were toxic and prostrated. The maximum number of stools per day were six, eight, and nine, respectively. Mucus was present in the feces of all three and one patient's feces showed streaks of blood. Sulfadiazine therapy was begun on the day following the challenge so that the cultures became negative almost immediately. In one instance a single positive finding was obtained on a culture made three weeks after the challenge, but sulfadiazine therapy was reinstituted and subsequent cultures taken over an 18-day period were negative.
These results seemed to indicate that the infected feces might have acted as an adjuvant. However, as we had used a mixture of four new strains in the last attempt, it was necessary to establish whether the new strains or the addition of feces was responsible for the production of clear-cut clinical dysentery. The next group consisted of eight individuals, four of whom received a total of 10 billion Flexner W, strains F II, III, IV, and V, in water, while the other four received the same number of organisms of the same strains and, in addition, each swallowed a capsule containing about 1 gm. of feces from a normal individual. All of the subjects who received organisms alone had severe clinical dysentery with maximum temperatures of 103 to 1040, four to ten watery stools containing blood and mucus, and moderately severe to severe cramps, vomiting, and chills. On the other hand, only one of the four who received the same dose of organisms plus normal feces had definite dysentery and his infection was milder than those experienced by the other group. Organisms appeared in the feces of the subjects receiving feces plus organisms just as early and persisted for as long as, or longer than, in those who were given organisms alone.
From these results it appeared that fecal material was not necessary and subsequent tests were performed with bacteria in water alone.
Since we wished to obtain an infectivity rate of about 50 per cent, the three individuals in the next group were given a mixture of 625 million of each of the four strains, FW II, FW III, FW IV, and FW V in water. The usual 2 gm. of sodium bicarbonate were administered five minutes previously. Two of these subjects had a moderate form of clinical dysentery with temperatures of 101.4 and 1020, three or four watery or semi-solid stools, cramps, and vomiting. Cultures became positive the day after the ingestion of the challenge culture and remained positive for from one to three days after sulfadiazine therapy was begun.
It would have been desirable if we could have determined, prior to further studies, whether any of the four strains used to infect the subjects in the last four groups of volunteers could produce infection when ingested alone or whether a combination of the strains was necessary. An insufficient number of volunteers remained, however, to make the extensive tests necessary to settle this point. It was, therefore, decided to challenge the vaccinated groups and their controls with mixtures of the four strains of Flexner W used in the experiments described above. The LDso for mice of this four-strain mixture was found to be 10-5.8. Subsequent tests with the single strains indicated that each one could produce clinical dysentery.
The vaccinated men and their unvaccinated controls were challenged with mixtures of the four strains used above in dosages of from one to four billion organisms. The results of these tests, which were negative, have been reported elsewhere.2 The incubation period, symptomatology, and duration of illness of the men included in these experiments have been tabulated and will be discussed here.
In analyzing the results it was necessary to define the clinical entity, dysentery. This was not easy, but it was finally decided that to be considered as a case of dysentery, the subject must have had a temperature of at least 100°F. by mouth during at least one of the four days following the feeding of Shigella organisms or he must have passed three or more stools, at least one of which was watery, during any one day of the week following the challenge. To be considered as a moderate or severe case of dysentery, the subject must have had a temperature of more than 1010 F. by mouth during at least one of the four days following the challenge and, in addition, at least three stools in one day or, alternatively, five or more stools during any one day, at least two of which were watery, and he must have experienced chills, severe cramps, or vomiting.
Based on these criteria 32 volunteers contracted mild dysentery and 51 moderate or severe dysentery, while 56 escaped infection entirely. Most of those who did not contract the disease received ineffective material during the course of the earlier experiments mentioned above. However, even in the later experiments, 23 of the 83 subjects escaped infection, regardless of their previous status in regard to vaccination.
In those subjects who developed the disease the incubation periods were remarkably short. All of those developing moderate or severe dysentery showed definite signs and symptoms within 24 hours after receiving the challenge dose. About one-fourth of these cases had incubation periods under 12 hours. In those who developed mild dysentery the incubation periods were somewhat lengthened. Twenty of the 32 cases developed definite signs of infection, such as diarrhea or temperature elevation over 1000 F., within 24 hours after challenge, nine in 24 to 36 hours, two in 36 to 48 hours and only one delveloped his first symptoms three days after the challenge. The incubation periods were short, initial symptoms usually appearing within 48 hours, even in those individuals who showed only mild abdominal cramps, headache, bloating, etc., such slight symptoms that a diagnosis of dysentery was questionable.
The signs and symptoms exhibited by the infected individuals are shown in Figs. 1 As would be expected, the duration of illness was longer in the group with moderate or severe dysentery than in those with mild infection. In the former, the mean duration of illness was about 3.5 days with a range from one to seven days. The curve of duration was quite symmetrical with 11 cases ill for three days and 11 cases for four days. In those showing mild dysentery the duration of the illness averaged about two days, the range being from one to six days, most of the cases being centered at one and two days' duration.
The relatively brief periods of illness shown by these cases can, we believe, be accounted for to a large extent by the prompt application of sulfadiazine and other types of symptomatic therapy. The fact that there were no carriers following sulfadiazine therapy is also worthy of mention. As indicated above, the infecting strain was known to be highly susceptible to the action of sulfadiazine and this undoubtedly accounts to a considerable extent for the rapid and effective results obtained by using this drug.
Summary and conclusions
Experimental bacillary dysentery can be successfully produced in man by ingestion of approximately one billion Shigella organisms in water.
A strain of Shigella which was most virulent for mice failed to produce clinical infection in man, while other strains of much lower virulence for mice produced moderate or severe dysentery in man.
The incubation period in the experimental disease was usually very short, rarely over 24 hours and never longer than 72 hours.
Because of the prominence of nausea and vomiting, moderate or severe bacillary dysentery might easily be confused on clinical grounds with food infections or intoxications due to Salmonella or staphylococci unless bacteriological tests are employed to determine the etiology.
Excretion of Shigella by asymptomatic individuals may begin within a few hours after ingestion and continue for some time.
Sulfadiazine effectively controlled bacillary dysentery produced by feeding sulfadiazine-susceptible strains of Shigella organisms and it rapidly suppressed the carrier state.
